INHALERX LIMITED - Announcements

0.00%

4.2¢

Market Cap $8.964M

Technology Scientific & Technical Instruments

InhaleRx Limited is an Australia-based healthcare company. The Company is focused on... InhaleRx Limited is an Australia-based healthcare company. The Company is focused on developing medicinal drug-device products to address unmet medical needs in the pain management and mental health sectors. It is engaged in the development of precision medicine delivered through inhalation. The Company is focused on the development of innovative inhaled therapeutics. The Company’s novel drug device combinations target the treatment of breakthrough cancer pain (BTcP) (IRX211) and panic disorder (PD)(IRX611a), with the objective of helping to improve the quality of life of BTcP and PD sufferers. IRX211 is a THC based synthetic cannabinoid derived drug (dronabinol) delivered via a pMDI in a fixed dose designed to provide rapid onset analgesia for patients suffering with acute episodic bursts of breakthrough pain. It holds an approved innovation patent and has lodged an Australian provisional patent application for the treatment of BTcP with the Australian Patent Office.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

IRX	Shareholder Webinar - 12pm AEDT on Wed 22 Nov 2023		20/11/23	164.65KB	Share
IRX	Clarification of claim against significant IRX shareholder		09/11/23	166.74KB	Share
IRX	Sep23 Appendix 4C	PRICE SENSITIVE	31/10/23	217.2KB	Share
IRX	Sep23 Quarterly Activities Report	PRICE SENSITIVE	31/10/23	253.01KB	Share
IRX	IRX presents at AusBioInvest 2023		30/10/23	9.09MB	Share
IRX	Ethics Application Submitted IRX616a Phase 2, Panic Disorder		18/10/23	190.03KB	Share
IRX	Key Milestone Achieved for IRX211 Phase 1 Pain Indication		12/09/23	172.1KB	Share
IRX	Half Yearly Report and Accounts	PRICE SENSITIVE	22/08/23	605.26KB	Share
IRX	Change of Company Secretary and Registered Office Address		03/08/23	139.37KB	Share
IRX	Quarterly Activities Report	PRICE SENSITIVE	31/07/23	235.94KB	Share
IRX	Quarterly Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/23	261.48KB	Share
IRX	Change of Director's Interest Notice		11/07/23	334.46KB	Share
IRX	Notification regarding unquoted securities - IRX		11/07/23	29.03KB	Share
IRX	First Cohort Complete for Phase 1, Pain Indication IRX211	PRICE SENSITIVE	14/06/23	191.69KB	Share
IRX	First Patient Dosed for Phase 1, Pain Indication IRX211	PRICE SENSITIVE	07/06/23	185.27KB	Share
IRX	Constitution		06/06/23	569.04KB	Share
IRX	Results of Meeting		26/05/23	137.37KB	Share
IRX	AGM Presentation		26/05/23	1.52MB	Share
IRX	Chairman's Address to Shareholders		26/05/23	193.87KB	Share
IRX	Quarterly Activities Report	PRICE SENSITIVE	28/04/23	250.67KB	Share
IRX	Quarterly Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/23	242.32KB	Share
IRX	Notice of Annual General Meeting/Proxy Form		26/04/23	1.14MB	Share
IRX	Annual Report to shareholders		30/03/23	1.17MB	Share
IRX	Appendix 4G & Corporate Governance Statement		30/03/23	559.7KB	Share
IRX	Ethics Approval for Phase 1 CRPS	PRICE SENSITIVE	21/03/23	199.97KB	Share
IRX	Change in substantial holding		02/03/23	120.82KB	Share
IRX	Section 708A Notice		01/03/23	127.13KB	Share
IRX	Appendix 2A		01/03/23	361.81KB	Share
IRX	Preliminary Final Report	PRICE SENSITIVE	27/02/23	508.59KB	Share
IRX	Results of Meeting		17/02/23	145.61KB	Share
IRX	EGM Presentation		17/02/23	2.36MB	Share
IRX	Chairman's address		17/02/23	146.11KB	Share
IRX	Notification regarding unquoted securities - IRX		13/02/23	37.56KB	Share
IRX	Quarterly Activities Report	PRICE SENSITIVE	31/01/23	533.6KB	Share
IRX	Quarterly Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/23	183.48KB	Share
IRX	Ceasing to be a substantial holder		23/01/23	223.88KB	Share
IRX	Notice of Extraordinary General Meeting/Proxy Form		18/01/23	1.55MB	Share
IRX	Contract Research Organisation Appointment	PRICE SENSITIVE	22/12/22	164.14KB	Share
IRX	Change of Director's Interest Notice		16/12/22	268.22KB	Share
IRX	Appendix 3G (Updated)		15/12/22	315.16KB	Share
IRX	Appendix 3G		15/12/22	271.7KB	Share
IRX	FDA Pre-IND Application Update		12/12/22	166.24KB	Share
IRX	Change in substantial holding		14/11/22	317.71KB	Share
IRX	Quarterly Activities Report	PRICE SENSITIVE	31/10/22	463.03KB	Share
IRX	Quarterly Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/22	304.91KB	Share
IRX	Change in substantial holding		19/10/22	190.95KB	Share
IRX	Section 708A Notice		10/10/22	150.08KB	Share
IRX	Initial Director's Interest Notice		04/10/22	243.8KB	Share
IRX	Final Director's Interest Notice		04/10/22	252.89KB	Share
IRX	Appendix 2A		03/10/22	294.93KB	Share
IRX	Appendix 2A		03/10/22	294.89KB	Share
IRX	Appendix 3B (updated)		03/10/22	507.27KB	Share
IRX	Board and Management Changes	PRICE SENSITIVE	27/09/22	127.28KB	Share
IRX	Appendix 3B (updated)		26/09/22	723.69KB	Share
IRX	Appendix 3B (updated)		26/09/22	722.58KB	Share
IRX	Update to Share Placement		26/09/22	146.7KB	Share
IRX	Proposed issue of securities - IRX		19/09/22	25.17KB	Share
IRX	Proposed issue of securities - IRX		19/09/22	24.5KB	Share
IRX	Private Placement to raise $1.2m	PRICE SENSITIVE	19/09/22	162.06KB	Share
IRX	Trading Halt	PRICE SENSITIVE	15/09/22	198.82KB	Share
IRX	Half Yearly Report and Accounts	PRICE SENSITIVE	31/08/22	1.52MB	Share
IRX	Quarterly Activities Report	PRICE SENSITIVE	28/07/22	692.28KB	Share
IRX	Quarterly Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/22	320.29KB	Share
IRX	Ceasing to be a substantial holder		04/07/22	729.29KB	Share
IRX	Notification of cessation of securities - IRX		07/06/22	21.42KB	Share
IRX	Constitution		06/06/22	581.92KB	Share
IRX	Results of Meeting		31/05/22	169.5KB	Share
IRX	AGM Presentation		31/05/22	1.57MB	Share
IRX	Chairman's address		31/05/22	192.39KB	Share
IRX	Quarterly Activities Report	PRICE SENSITIVE	29/04/22	442.74KB	Share
IRX	Quarterly Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/22	297.77KB	Share
IRX	Annual General Meeting Letter to Shareholders		28/04/22	254.09KB	Share
IRX	Notice of Annual General Meeting/Proxy Form		28/04/22	477.83KB	Share
IRX	Appendix 4G & Corporate Governance Statement		31/03/22	560.12KB	Share
IRX	Annual Report to shareholders		31/03/22	1.06MB	Share
IRX	IRX granted wholesale licenses for scheduled substances		30/03/22	174.25KB	Share
IRX	Preliminary Final Report	PRICE SENSITIVE	28/02/22	449.46KB	Share
IRX	Quarterly Activities Report	PRICE SENSITIVE	31/01/22	542.82KB	Share
IRX	Quarterly Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/22	245.54KB	Share
IRX	InhaleRx Ltd appoints Executive Director	PRICE SENSITIVE	29/12/21	172.09KB	Share
IRX	Change in substantial holding		21/12/21	119.2KB	Share
IRX	Change of Director's Interest Notice		03/12/21	219.79KB	Share
IRX	Securities Trading Policy		01/12/21	332.54KB	Share
IRX	Quarterly Activities Report	PRICE SENSITIVE	01/11/21	381.78KB	Share
IRX	Appendix 4C Cash Flow Report	PRICE SENSITIVE	01/11/21	2.17MB	Share
IRX	Change of Share Registry Details		29/10/21	90.64KB	Share
IRX	Change of Registered Office Address		26/10/21	85.02KB	Share
IRX	Change in substantial holding		13/10/21	207.49KB	Share
IRX	Change of Director's Interest Notice		13/10/21	83.99KB	Share
IRX	Company Name Change and New ASX Code 'IRX'		05/10/21	139.72KB	Share
IRX	Results of Meeting		15/09/21	152.56KB	Share
IRX	EGM Presentation		15/09/21	1.45MB	Share
IRX	Change of Director's Interest Notice		01/09/21	289.12KB	Share
IRX	Half Yearly Report and Accounts	PRICE SENSITIVE	01/09/21	1.24MB	Share
IRX	Change in substantial holding		19/08/21	126KB	Share
IRX	Notice of Extraordinary General Meeting/Proxy Form		17/08/21	344.38KB	Share
IRX	Extraordinary General Meeting Letter to Shareholders		17/08/21	120.94KB	Share
IRX	Initial Director's Interest Notice		02/08/21	186.41KB	Share
IRX	Final Director's Interest Notice		02/08/21	189.84KB	Share
IRX	Results of Meeting		30/07/21	164.13KB	Share

IRX Shareholder Webinar - 12pm AEDT on Wed 22 Nov 2023
20/11/23		164.65KB	Share
IRX Clarification of claim against significant IRX shareholder
09/11/23		166.74KB	Share
IRX Sep23 Appendix 4C
31/10/23	PRICE SENSITIVE	217.2KB	Share
IRX Sep23 Quarterly Activities Report
31/10/23	PRICE SENSITIVE	253.01KB	Share
IRX IRX presents at AusBioInvest 2023
30/10/23		9.09MB	Share
IRX Ethics Application Submitted IRX616a Phase 2, Panic Disorder
18/10/23		190.03KB	Share
IRX Key Milestone Achieved for IRX211 Phase 1 Pain Indication
12/09/23		172.1KB	Share
IRX Half Yearly Report and Accounts
22/08/23	PRICE SENSITIVE	605.26KB	Share
IRX Change of Company Secretary and Registered Office Address
03/08/23		139.37KB	Share
IRX Quarterly Activities Report
31/07/23	PRICE SENSITIVE	235.94KB	Share
IRX Quarterly Appendix 4C Cash Flow Report
31/07/23	PRICE SENSITIVE	261.48KB	Share
IRX Change of Director's Interest Notice
11/07/23		334.46KB	Share
IRX Notification regarding unquoted securities - IRX
11/07/23		29.03KB	Share
IRX First Cohort Complete for Phase 1, Pain Indication IRX211
14/06/23	PRICE SENSITIVE	191.69KB	Share
IRX First Patient Dosed for Phase 1, Pain Indication IRX211
07/06/23	PRICE SENSITIVE	185.27KB	Share
IRX Constitution
06/06/23		569.04KB	Share
IRX Results of Meeting
26/05/23		137.37KB	Share
IRX AGM Presentation
26/05/23		1.52MB	Share
IRX Chairman's Address to Shareholders
26/05/23		193.87KB	Share
IRX Quarterly Activities Report
28/04/23	PRICE SENSITIVE	250.67KB	Share
IRX Quarterly Appendix 4C Cash Flow Report
28/04/23	PRICE SENSITIVE	242.32KB	Share
IRX Notice of Annual General Meeting/Proxy Form
26/04/23		1.14MB	Share
IRX Annual Report to shareholders
30/03/23		1.17MB	Share
IRX Appendix 4G & Corporate Governance Statement
30/03/23		559.7KB	Share
IRX Ethics Approval for Phase 1 CRPS
21/03/23	PRICE SENSITIVE	199.97KB	Share
IRX Change in substantial holding
02/03/23		120.82KB	Share
IRX Section 708A Notice
01/03/23		127.13KB	Share
IRX Appendix 2A
01/03/23		361.81KB	Share
IRX Preliminary Final Report
27/02/23	PRICE SENSITIVE	508.59KB	Share
IRX Results of Meeting
17/02/23		145.61KB	Share
IRX EGM Presentation
17/02/23		2.36MB	Share
IRX Chairman's address
17/02/23		146.11KB	Share
IRX Notification regarding unquoted securities - IRX
13/02/23		37.56KB	Share
IRX Quarterly Activities Report
31/01/23	PRICE SENSITIVE	533.6KB	Share
IRX Quarterly Appendix 4C Cash Flow Report
31/01/23	PRICE SENSITIVE	183.48KB	Share
IRX Ceasing to be a substantial holder
23/01/23		223.88KB	Share
IRX Notice of Extraordinary General Meeting/Proxy Form
18/01/23		1.55MB	Share
IRX Contract Research Organisation Appointment
22/12/22	PRICE SENSITIVE	164.14KB	Share
IRX Change of Director's Interest Notice
16/12/22		268.22KB	Share
IRX Appendix 3G (Updated)
15/12/22		315.16KB	Share
IRX Appendix 3G
15/12/22		271.7KB	Share
IRX FDA Pre-IND Application Update
12/12/22		166.24KB	Share
IRX Change in substantial holding
14/11/22		317.71KB	Share
IRX Quarterly Activities Report
31/10/22	PRICE SENSITIVE	463.03KB	Share
IRX Quarterly Appendix 4C Cash Flow Report
31/10/22	PRICE SENSITIVE	304.91KB	Share
IRX Change in substantial holding
19/10/22		190.95KB	Share
IRX Section 708A Notice
10/10/22		150.08KB	Share
IRX Initial Director's Interest Notice
04/10/22		243.8KB	Share
IRX Final Director's Interest Notice
04/10/22		252.89KB	Share
IRX Appendix 2A
03/10/22		294.93KB	Share
IRX Appendix 2A
03/10/22		294.89KB	Share
IRX Appendix 3B (updated)
03/10/22		507.27KB	Share
IRX Board and Management Changes
27/09/22	PRICE SENSITIVE	127.28KB	Share
IRX Appendix 3B (updated)
26/09/22		723.69KB	Share
IRX Appendix 3B (updated)
26/09/22		722.58KB	Share
IRX Update to Share Placement
26/09/22		146.7KB	Share
IRX Proposed issue of securities - IRX
19/09/22		25.17KB	Share
IRX Proposed issue of securities - IRX
19/09/22		24.5KB	Share
IRX Private Placement to raise $1.2m
19/09/22	PRICE SENSITIVE	162.06KB	Share
IRX Trading Halt
15/09/22	PRICE SENSITIVE	198.82KB	Share
IRX Half Yearly Report and Accounts
31/08/22	PRICE SENSITIVE	1.52MB	Share
IRX Quarterly Activities Report
28/07/22	PRICE SENSITIVE	692.28KB	Share
IRX Quarterly Appendix 4C Cash Flow Report
28/07/22	PRICE SENSITIVE	320.29KB	Share
IRX Ceasing to be a substantial holder
04/07/22		729.29KB	Share
IRX Notification of cessation of securities - IRX
07/06/22		21.42KB	Share
IRX Constitution
06/06/22		581.92KB	Share
IRX Results of Meeting
31/05/22		169.5KB	Share
IRX AGM Presentation
31/05/22		1.57MB	Share
IRX Chairman's address
31/05/22		192.39KB	Share
IRX Quarterly Activities Report
29/04/22	PRICE SENSITIVE	442.74KB	Share
IRX Quarterly Appendix 4C Cash Flow Report
29/04/22	PRICE SENSITIVE	297.77KB	Share
IRX Annual General Meeting Letter to Shareholders
28/04/22		254.09KB	Share
IRX Notice of Annual General Meeting/Proxy Form
28/04/22		477.83KB	Share
IRX Appendix 4G & Corporate Governance Statement
31/03/22		560.12KB	Share
IRX Annual Report to shareholders
31/03/22		1.06MB	Share
IRX IRX granted wholesale licenses for scheduled substances
30/03/22		174.25KB	Share
IRX Preliminary Final Report
28/02/22	PRICE SENSITIVE	449.46KB	Share
IRX Quarterly Activities Report
31/01/22	PRICE SENSITIVE	542.82KB	Share
IRX Quarterly Appendix 4C Cash Flow Report
31/01/22	PRICE SENSITIVE	245.54KB	Share
IRX InhaleRx Ltd appoints Executive Director
29/12/21	PRICE SENSITIVE	172.09KB	Share
IRX Change in substantial holding
21/12/21		119.2KB	Share
IRX Change of Director's Interest Notice
03/12/21		219.79KB	Share
IRX Securities Trading Policy
01/12/21		332.54KB	Share
IRX Quarterly Activities Report
01/11/21	PRICE SENSITIVE	381.78KB	Share
IRX Appendix 4C Cash Flow Report
01/11/21	PRICE SENSITIVE	2.17MB	Share
IRX Change of Share Registry Details
29/10/21		90.64KB	Share
IRX Change of Registered Office Address
26/10/21		85.02KB	Share
IRX Change in substantial holding
13/10/21		207.49KB	Share
IRX Change of Director's Interest Notice
13/10/21		83.99KB	Share
IRX Company Name Change and New ASX Code 'IRX'
05/10/21		139.72KB	Share
IRX Results of Meeting
15/09/21		152.56KB	Share
IRX EGM Presentation
15/09/21		1.45MB	Share
IRX Change of Director's Interest Notice
01/09/21		289.12KB	Share
IRX Half Yearly Report and Accounts
01/09/21	PRICE SENSITIVE	1.24MB	Share
IRX Change in substantial holding
19/08/21		126KB	Share
IRX Notice of Extraordinary General Meeting/Proxy Form
17/08/21		344.38KB	Share
IRX Extraordinary General Meeting Letter to Shareholders
17/08/21		120.94KB	Share
IRX Initial Director's Interest Notice
02/08/21		186.41KB	Share
IRX Final Director's Interest Notice
02/08/21		189.84KB	Share
IRX Results of Meeting
30/07/21		164.13KB	Share

REFRESH

First 2 3 4

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 4.2¢		Change 0.000(0.00%)		Mkt cap ! $8.964M

Open	High	Low	Value	Volume
4.2¢	4.2¢	4.2¢	$1.05K	25K

Buyers (Bids)

No.	Vol.	Price($)
1	15000	3.7¢

Sellers (Offers)

Price($)	Vol.	No.
4.2¢	25000	1

View Market Depth

No.	Vol.	Price($)
1	15000	0.037
1	38000	0.033
1	347441	0.015
1	70000	0.014
1	80000	0.012

Price($)	Vol.	No.
0.042	25000	1
0.043	667947	2
0.044	244286	1
0.048	133696	1
0.050	955710	4

Last trade - 10.16am 01/08/2025 (20 minute delay)

IRX (ASX) Chart

INHALERX LIMITED - Announcements

Corporate Spotlight
Not Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Codeifai looks to ride AI wave as Quantum Computing becomes a necessity

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories

INHALERX LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Codeifai looks to ride AI wave as Quantum Computing becomes a necessity

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories

Corporate Spotlight
Not Yet Available